Showing results (1491-1500 of 1,588) with videos related to

Sort By:
Pageof 159
BMJ Open|July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2019
Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial PathogensElena Mitsi, Beatriz Carniel, Jesús Reiné, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignanciesKaren W L Yee, Anne Hagey, Srdan Verstovsek, et al.
Pharmacogenetics and Genomics|May 15, 2013
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751Federico Innocenti, Jacqueline Ramírez, Jennifer Obel, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 15, 2017
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDYEliza B Geer, Ismat Shafiq, Murray B Gordon, et al.
Human Genetics|November 20, 2018
Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutationsDavor Lessel, Ayse Bilge Ozel, Susan E Campbell, et al.
Vaccine|April 3, 2024
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisationG Tembo, M Mayuni, R Kamng'ona, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Annals of the American Thoracic Society|February 27, 2025
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and OutcomesInnocent Sulani, Lauren A Onofrey, Letizia Trevisi, et al.
Pageof 159